The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by ...

The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...

It would give millions of people access to weekly injectables that have helped people shed pounds so quickly that some people ...

More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...

According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, ...

The guidelines are part of a national trend by municipal governments and private firms struggling to manage ballooning costs ...

Weight-loss drug makers are directly targeting employers in a campaign to expand health insurance coverage of their popular, ...